RecruitingNCT05014399

Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

Sponsor

Joseph McCollom

Enrollment

60 participants

Start Date

Sep 20, 2021

Study Type

OBSERVATIONAL

Conditions

Chemotherapy Effect Cognitive Change Cognitive Impairment Chemo-brain Cognitive Dysfunction Cognitive Decline Neoplasm, Colorectal Chemo Fog

Summary

The purpose of this research study is to see how the brain changes in patients receiving chemotherapy (cytotoxic drug) treatment for colon or rectal cancer at Parkview Cancer Institute. This information will be used to identify helpful tests to diagnose individuals at risk for developing difficulties with thinking and memory due to their cancer treatments.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study investigates whether chemotherapy for colorectal cancer causes thinking or memory problems — a side effect sometimes called "chemo brain." Researchers will monitor cognitive function before, during, and after treatment. **You may be eligible if...** - You have been diagnosed with colorectal cancer confirmed by biopsy - You are scheduled to begin chemotherapy treatment - You are 18 or older - You are able to provide written informed consent - Your overall health is stable enough to participate in follow-up assessments **You may NOT be eligible if...** - You are not planned to receive chemotherapy for colorectal cancer - You have a pre-existing neurological condition that significantly affects thinking or memory - You are unable to complete cognitive assessments - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.